| scholarly article | Q13442814 |
| P50 | author | Grant R. Drummond | Q37383500 |
| P2093 | author name string | Gregory J Dusting | |
| Mark Ng Tang Fui | |||
| Nancy Guzzo-Pernell | |||
| Sara H M Ellmark | |||
| P433 | issue | 2 | |
| P304 | page(s) | 495-504 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle | |
| P478 | volume | 65 |
| Q46449981 | A novel antioxidant peptide derived from wheat germ prevents high glucose-induced oxidative stress in vascular smooth muscle cells in vitro. |
| Q39893903 | Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species |
| Q38744716 | Advanced Glycation End-Products Induce Apoptosis of Vascular Smooth Muscle Cells: A Mechanism for Vascular Calcification |
| Q34455371 | Apocynin-treatment reverses hyperoxaluria induced changes in NADPH oxidase system expression in rat kidneys: a transcriptional study |
| Q36481340 | Aquaporin 1, Nox1, and Ask1 mediate oxidant-induced smooth muscle cell hypertrophy |
| Q36012825 | Are we over oxidized? Oxidative stress, cardiovascular disease, and the future of intervention studies with antioxidants |
| Q26991619 | Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system |
| Q38856689 | Central Nervous System Injury and Nicotinamide Adenine Dinucleotide Phosphate Oxidase: Oxidative Stress and Therapeutic Targets |
| Q37849579 | Chlamydia pneumoniae induces a pro-inflammatory phenotype in murine vascular smooth muscle cells independently of elevating reactive oxygen species |
| Q36772931 | Clinical pharmacology and therapeutic use of antioxidant vitamins |
| Q35992729 | Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets |
| Q38132120 | Current status of NADPH oxidase research in cardiovascular pharmacology |
| Q58126981 | Cytochrome P450 1B1 Is Critical for Neointimal Growth in Wire-Injured Carotid Artery of Male Mice |
| Q35723863 | DNA damage induces reactive oxygen species generation through the H2AX-Nox1/Rac1 pathway. |
| Q28588922 | Decreased blood pressure in NOX1-deficient mice |
| Q28585549 | Differential expression of NADPH oxidases in megakaryocytes and their role in polyploidy |
| Q37600276 | Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor-alpha in human aortic smooth muscle and embryonic kidney cells |
| Q33883879 | Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells. |
| Q64055438 | EGFP-EGF1-conjugated poly(lactic-co-glycolic acid) nanoparticles, a new diagnostic tool and drug carrier for atherosclerosis |
| Q36916964 | Effect of gender and sex hormones on vascular oxidative stress. |
| Q35839118 | Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE⁻/⁻ mice |
| Q37084544 | Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species |
| Q41850485 | Eplerenone suppresses aldosterone/ salt-induced expression of NOX-4. |
| Q35883952 | Ethanol induces oxidative stress in alveolar macrophages via upregulation of NADPH oxidases |
| Q38057744 | From form to function: the role of Nox4 in the cardiovascular system |
| Q39334544 | Functional Role of Nox4 in Autophagy. |
| Q37629236 | Glutathione attenuates ethanol-induced alveolar macrophage oxidative stress and dysfunction by downregulating NADPH oxidases |
| Q28569716 | HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis |
| Q38905577 | High-glucose-increased expression and activation of NADPH oxidase in human vascular smooth muscle cells is mediated by 4-hydroxynonenal-activated PPARα and PPARβ/δ. |
| Q30786020 | Hu antigen R is required for NOX-1 but not NOX-4 regulation by inflammatory stimuli in vascular smooth muscle cells. |
| Q37942731 | Hydrogen peroxide: a Jekyll and Hyde signalling molecule |
| Q35612393 | Hyperglycemia enhances IGF-I-stimulated Src activation via increasing Nox4-derived reactive oxygen species in a PKCζ-dependent manner in vascular smooth muscle cells |
| Q50900704 | Inhibition of reactive oxygen species generation attenuates TLR4-mediated proinflammatory and proliferative phenotype of vascular smooth muscle cells. |
| Q37141472 | Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feeding |
| Q64986661 | Intravenous Anesthetic Protects Hepatocyte from Reactive Oxygen Species-Induced Cellular Apoptosis during Liver Transplantation In Vivo. |
| Q42033152 | Lack of Fibronectin Extra Domain A Alternative Splicing Exacerbates Endothelial Dysfunction in Diabetes |
| Q41971809 | Long-Term Chronic Intermittent Hypobaric Hypoxia in Rats Causes an Imbalance in the Asymmetric Dimethylarginine/Nitric Oxide Pathway and ROS Activity: A Possible Synergistic Mechanism for Altitude Pulmonary Hypertension? |
| Q33593365 | NAD(P)H oxidases in coronary artery disease. |
| Q99408850 | NADPH oxidase 4 and its role in the cardiovascular system |
| Q36501270 | NADPH oxidase 4 is required for interleukin-1β-mediated activation of protein kinase Cδ and downstream activation of c-jun N-terminal kinase signaling in smooth muscle |
| Q37766127 | NADPH oxidase and cardiac failure. |
| Q27014373 | NADPH oxidase as a therapeutic target for oxalate induced injury in kidneys |
| Q90576094 | NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets |
| Q42072724 | NADPH oxidases are responsible for the failure of nitric oxide to inhibit migration of smooth muscle cells exposed to high glucose. |
| Q27001094 | NADPH oxidases in heart failure: poachers or gamekeepers? |
| Q33739287 | NADPH oxidases: functions and pathologies in the vasculature |
| Q37176104 | NOX enzymes as novel targets for drug development |
| Q36267903 | NOX1 and NOX4 are required for the differentiation of mouse F9 cells into extraembryonic endoderm |
| Q40133141 | NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. |
| Q57821326 | Nanoparticles in Medicine: A Focus on Vascular Oxidative Stress |
| Q37175017 | Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers |
| Q33744942 | Nox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries |
| Q37760616 | Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models. |
| Q37392163 | Nox proteins in signal transduction |
| Q42393608 | Nox4 contributes to the hypoxia-mediated regulation of actin cytoskeleton in cerebrovascular smooth muscle |
| Q42099958 | Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype |
| Q35213232 | Nox4: a hydrogen peroxide-generating oxygen sensor |
| Q59465393 | Opposing actions of rosiglitazone and resveratrol on mineralization in human vascular smooth muscle cells |
| Q47851814 | Overexpression of the Neuronal Human (Pro)renin Receptor Mediates Angiotensin II-Independent Blood Pressure Regulation in the Central Nervous System |
| Q37501271 | Oxidative stress and cardiovascular disease: novel tools give (free) radical insight |
| Q38131402 | Oxidative stress and microRNAs in vascular diseases. |
| Q35964957 | PVN adenovirus-siRNA injections silencing either NOX2 or NOX4 attenuate aldosterone/NaCl-induced hypertension in mice |
| Q38089739 | Pharmacological approaches to the treatment of oxidative stress-induced cardiovascular dysfunctions |
| Q35222727 | Protein disulfide isomerase expression increases in resistance arteries during hypertension development. Effects on Nox1 NADPH oxidase signaling |
| Q33995716 | Pulmonary oxidative stress is increased in cyclooxygenase-2 knockdown mice with mild pulmonary hypertension induced by monocrotaline |
| Q44034196 | RNAi-mediated silencing of NOX4 inhibited the invasion of gastric cancer cells through JAK2/STAT3 signaling |
| Q36450264 | Reactive oxygen species signaling in vascular smooth muscle cells |
| Q38053776 | Recent development in the effects of statins on cardiovascular disease through Rac1 and NADPH oxidase |
| Q36890594 | Recruitment of Nox4 to a plasma membrane scaffold is required for localized reactive oxygen species generation and sustained Src activation in response to insulin-like growth factor-I. |
| Q37795167 | Redox regulation of Nox proteins |
| Q37446110 | Redox signaling in cardiovascular health and disease. |
| Q35925959 | Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems |
| Q33772560 | Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins |
| Q36666637 | Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases |
| Q37445914 | Role of NADPH oxidase in atherosclerosis |
| Q36842965 | Role of nicotinamide adenine dinucleotide phosphate-reduced oxidase proteins in Pseudomonas aeruginosa-induced lung inflammation and permeability |
| Q47101699 | Schwann cell TRPA1 mediates neuroinflammation that sustains macrophage-dependent neuropathic pain in mice |
| Q58075704 | Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation |
| Q26853670 | Stop the flow: a paradigm for cell signaling mediated by reactive oxygen species in the pulmonary endothelium |
| Q39909686 | Superoxide production: a procalcifying cell signalling event in osteoblastic differentiation of vascular smooth muscle cells exposed to calcification media |
| Q54540983 | Systemic upregulation of NADPH oxidase in diet-induced obesity in rats. |
| Q36444961 | TLR4 regulates pulmonary vascular homeostasis and remodeling via redox signaling |
| Q92241365 | Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation |
| Q39306993 | The Importance of NADPH Oxidases and Redox Signaling in Angiogenesis. |
| Q38018554 | The NADPH oxidase family and its inhibitors. |
| Q37954511 | The Nox family of NADPH oxidases: friend or foe of the vascular system? |
| Q26771758 | The Role of Oxidative Stress in Neurodegenerative Diseases |
| Q36105708 | Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysema |
| Q42658762 | Transcriptional regulation of Nox4 by histone deacetylases in human endothelial cells. |
| Q42409338 | Upregulation of Nox4 by TGF{beta}1 oxidizes SERCA and inhibits NO in arterial smooth muscle of the prediabetic Zucker rat. |
| Q37380419 | Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling |
| Q60047032 | Vascular Oxidative Stress: Impact and Therapeutic Approaches |
| Q34479731 | Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease |
Search more.